XTemporal response of the human virome to immunosuppression and antiviral therapy

Cell

Volumn 155, Issue 5, 2013, Pages 1178-

  De Vlaminck, Iwijn ^a   Khush, Kiran K ^b   Strehl, Calvin ^b   Kohli, Bitika ^b   Luikart, Helen ^b   Neff, Norma F ^a   Okamoto, Jennifer ^a   Snyder, Thomas M ^a   Cornfield, David N ^b   Nicolls, Mark R ^b   Weill, David ^b   Bernstein, Daniel ^b   Valantine, Hannah A ^b   Quake, Stephen R ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VALGANCICLOVIR;

ANELLOVIRUS; ANTIVIRAL SUSCEPTIBILITY; ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DNA EXTRACTION; DNA SEQUENCE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EXPOSURE; DRUG MEGADOSE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MICROBIOME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS LOAD; VIRUS MORPHOLOGY;

BACTERIA (MICROORGANISMS);

EID: 84889594211     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.10.034     Document Type: Article

References (42)

1. Avivi, I., Chakrabarti, S., Milligan, D.W., Waldmann, H., Hale, G., Osman, H., Ward, K.N., Fegan, C.D., Yong, K., Goldstone, A.H., et al. (2004). Incidence and outcome of adenovirus disease in transplant recipients after reducedintensity conditioning with alemtuzumab. Biol. Blood Marrow Transplant. 10, 186-194.
2. Bruno, B., Gooley, T., Hackman, R.C., Davis, C., Corey, L., and Boeckh, M. (2003). Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol. Blood Marrow Transplant. 9, 341-352.
3. Budde, K., Matz, M., Dürr, M., and Glander, P. (2011). Biomarkers of overimmunosuppression. Clin. Pharmacol. Ther. 90, 316-322.
4. Chesters, P.M., Heritage, J., and McCance, D.J. (1983). Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147, 676-684.
5. Clemente, J.C., Ursell, L.K., Parfrey, L.W., and Knight, R. (2012). The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270.
6. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Collini, S., Pieraccini, G., and Lionetti, P. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 107, 14691-14696.
7. Fan, H.C., Blumenfeld, Y.J., Chitkara, U., Hudgins, L., and Quake, S.R. (2008). Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. USA 105, 16266-16271.
8. Fishman, J.A. (2007). Infection in solid-organ transplant recipients. N. Engl. J. Med. 357, 2601-2614.
9. Fishman, J.A., Emery, V., Freeman, R., Pascual, M., Rostaing, L., Schlitt, H.J., Sgarabotto, D., Torre-Cisneros, J., and Uknis, M.E. (2007). Cytomegalovirus in transplantation - challenging the status quo. Clin. Transplant. 21, 149-158.
10. Hino, S., and Miyata, H. (2007). Torque teno virus (TTV): current status. Rev. Med. Virol. 17, 45-57.
11. Jakobsson, H.E., Jernberg, C., Andersson, A.F., Sjölund-Karlsson, M., Jansson, J.K., and Engstrand, L. (2010). Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5, e9836.
12. Jusko, W.J., Piekoszewski, W., Klintmalm, G.B., Shaefer, M.S., Hebert, M.F., Piergies, A.A., Lee, C.C., Schechter, P., and Mekki, Q.A. (1995). Pharmacokinetics of tacrolimus in liver transplant patients. Clin. Pharmacol. Ther. 57, 281-290.
13. Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760.
14. Madsen, C.D., Eugen-Olsen, J., Kirk, O., Parner, J., Kaae Christensen, J., Brasholt, M.S., Ole Nielsen, J., and Krogsgaard, K. (2002). TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patients. HIV Clin. Trials 3, 287-295.
15. Marboe, C.C., Billingham, M., Eisen, H., Deng, M.C., Baron, H., Mehra, M., Hunt, S., Wohlgemuth, J., Mahmood, I., Prentice, J., and Berry, G. (2005). Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J. Heart Lung Transplant. Suppl. 24, S219-S226.
16. McElvania TeKippe, E., Wylie, K.M., Deych, E., Sodergren, E., Weinstock, G., and Storch, G.A. (2012). Increased prevalence of anellovirus in pediatric patients with fever. PLoS ONE 7, e50937.
17. Minot, S., Sinha, R., Chen, J., Li, H., Keilbaugh, S.A., Wu, G.D., Lewis, J.D., and Bushman, F.D. (2011). The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21, 1616-1625.
18. Muegge, B.D., Kuczynski, J., Knights, D., Clemente, J.C., González, A., Fontana, L., Henrissat, B., Knight, R., and Gordon, J.I. (2011). Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332, 970-974.
19. Oksanen, J., Kindt, R., Legendre, P., O'Hara, B., Stevens, M.H.H., Oksanen, M.J., and Suggests, M. (2007). The vegan package. Community ecology package. Version 2.0-7.
20. Potena, L., Holweg, C.T., Vana, M.L., Bashyam, L., Rajamani, J., McCormick, A.L., Cooke, J.P., Valantine, H.A., and Mocarski, E.S. (2007). Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J. Clin. Microbiol. 45, 1804-1810.
21. Razonable, R.R. (2011). Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin. Proc. 86, 1009-1026.
22. Razonable, R.R., Brown, R.A., Humar, A., Covington, E., Alecock, E., and Paya, C.V.; PV16000 Study Group. (2005). A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J. Infect. Dis. 192, 1349-1354.
23. Reyes, A., Haynes, M., Hanson, N., Angly, F.E., Heath, A.C., Rohwer, F., and Gordon, J.I. (2010). Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334-338.
24. Rossano, J.W., Denfield, S.W., Kim, J.J., Price, J.F., Jefferies, J.L., Decker, J.A., Smith, E.O.B., Clunie, S.K., Towbin, J.A., and Dreyer, W.J. (2009). Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J. Heart Lung Transplant. 28, 26-31.
25. Saraiva, F., Matos, V., Gonç alves, L., Antunes, M., and Providência, L.A. (2011). Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures. Transplant. Proc. 43, 1908-1912.
26. Schowalter, R.M., Pastrana, D.V., Pumphrey, K.A., Moyer, A.L., and Buck, C.B. (2010). Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7, 509-515.
27. Sia, I.G., Wilson, J.A., Groettum, C.M., Espy, M.J., Smith, T.F., and Paya, C.V. (2000). Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J. Infect. Dis. 181, 717-720.
28. Sing, T., Sander, O., Beerenwinkel, N., and Lengauer, T. (2005). ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940-3941.
29. Slifkin, M., Doron, S., and Snydman, D.R. (2004). Viral prophylaxis in organ transplant patients. Drugs 64, 2763-2792.
30. Snyder, T.M., Khush, K.K., Valantine, H.A., and Quake, S.R. (2011). Universal noninvasive detection of solid organ transplant rejection. Proc. Natl. Acad. Sci. USA 108, 6229-6234.
31. Stewart, S., Winters, G.L., Fishbein, M.C., Tazelaar, H.D., Kobashigawa, J., Abrams, J., Andersen, C.B., Angelini, A., Berry, G.J., Burke, M.M., et al. (2005). Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J. Heart Lung Transplant. 24, 1710-1720.
32. Thom, K., and Petrik, J. (2007). Progression towards AIDS leads to increased Torque teno virus and Torque teno minivirus titers in tissues of HIV infected individuals. J. Med. Virol. 79, 1-7.
33. Touinssi, M., Gallian, P., Biagini, P., Attoui, H., Vialettes, B., Berland, Y., Tamalet, C., Dhiver, C., Ravaux, I., De Micco, P., and De Lamballerie, X. (2001). TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load. J. Clin. Virol. 21, 135-141.
34. Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., and Gordon, J.I. (2007). The human microbiome project. Nature 449, 804-810.
35. Venkataramanan, R., Swaminathan, A., Prasad, T., Jain, A., Zuckerman, S., Warty, V., McMichael, J., Lever, J., Burckart, G., and Starzl, T. (1995). Clinical pharmacokinetics of tacrolimus. Clin. Pharmacokinet. 29, 404-430.
36. Weber, G., Shendure, J., Tanenbaum, D.M., Church, G.M., and Meyerson, M. (2002). Identification of foreign gene sequences by transcript filtering against the human genome. Nat. Genet. 30, 141-142.
37. Wieland, E., Olbricht, C.J., Süsal, C., Gurragchaa, P., Böhler, T., Israeli, M., Sommerer, C., Budde, K., Hartmann, B., Shipkova, M., and Oellerich, M. (2010). Biomarkers as a tool for management of immunosuppression in transplant patients. Ther. Drug Monit. 32, 560-572.
38. Wylie, K.M., Weinstock, G.M., and Storch, G.A. (2012). Emerging view of the human virome. Transl. Res. 160, 283-290.
39. Xia, L.C., Cram, J.A., Chen, T., Fuhrman, J.A., and Sun, F. (2011). Accurate genome relative abundance estimation based on shotgun metagenomic reads. PLoS ONE 6, e27992.
40. Xu, Y., Stange-Thomann, N., Weber, G., Bo, R., Dodge, S., David, R.G., Foley, K., Beheshti, J., Harris, N.L., Birren, B., et al. (2003). Pathogen discovery from human tissue by sequence-based computational subtraction. Genomics 81, 329-335.
41. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., et al. (2012). Human gut microbiome viewed across age and geography. Nature 486, 222-227.
42. zur Hausen, H., and de Villiers, E.M. (2009). TT viruses: oncogenic or tumor-suppressive properties? Curr. Top. Microbiol. Immunol. 331, 109-116.